PE investors play a major role in portfolio management in the chemical and pharmaceutical industry. They invest in business units that are outsourced by companies for strategic or economic reasons. Sapherior as an industry expert supports PE investors with a well-founded assessment of the business case and industry development as well as with the selection of suitable targets. With our outstanding process, market and often detailed company knowledge, Sapherior supports you in pricing as well as in the strategic and organizational development of the company to be spun off. When it comes to acquisitions in the context of a„buy&build“ strategy or the sale or exit, Sapherior is also a partner for the identification of targets or potential buyers.